Skip to main content

Advertisement

Table 1 Enrolled participants characteristics

From: Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

Participants (n = 78)
Gender
 Males (%) 26 (33.3)
 Females (%) 52 (66.7)
Age (years)
 Range 23–69
 Mean age 35
Baseline CD4 counts (cells/μl)  
  < 200 39
 200–349 34
  ≥ 350 5
 Mean CD4 count 192
Travel history/Stay outside South Africa
 None 56
 Central Africa 2
 North Africa 1
 Southern Africa 28
 West Africa 2
 Europe 3
Years since HIV diagnosis
  < 1 61
 1–5 15
  > 5 2